Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 68475-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 68475-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2ff6227b 08a2 471e 8b3c B1ec47b43248 02
2ff6227b 08a2 471e 8b3c B1ec47b43248 03
2ff6227b 08a2 471e 8b3c B1ec47b43248 04
This is a description of Sodium Phenylacetate and Sodium Benzoate Injection, a 10% / 10% solution for intravenous use only. The injection should be administered through a central line and must be diluted with sterile, dextrose injection, 10% (D10W) before use. Each 50mL vial contains 100mg of sodium phenylacetate and 100mg of sodium benzoate. Sodium hydroxide and/or hydrochloric acid may have been used for pH adjustment. The injection is sterile, non-pyrogenic, and is a single-dose vial. The manufacturer is Navinta LLC, located in Ewing, NJ. Storage instructions recommend keeping the product between 15°-30°C (59°-86°F) and it should be kept out of reach of children. The dosage should be determined after consulting the accompanying package insert. The text contains a lot of unreadable characters indicating errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.